KURA ONE, Compact Cans of Japanese Sake Featuring Brands From Award-winning Sake Breweries in Japan and Overseas, Is Now Available as a Subscription Service Delivered Worldwide!
28.2.2023 11:00:00 EET | Business Wire | Press release
KURA ONE meticulously selects sake from brands of award-winning sake breweries in Japan and overseas and repackages them in compact and easy-to-handle 180ml/196g aluminum cans, while maintaining the quality of the sake. On January 31, the first canned sake subscription service in the world that delivers sake, along with stories about enjoying sake, directly to customers via subscription in more than 100 countries has launched online ordering. As a result of the service's introduction in numerous media sources, it has been attracting attention in Japan.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230223006067/en/
Sake breweries from different regions also participated in the press conference. (Photo: Business Wire)
“KURA ONE Sales Commemorative Special Edition,” which is a complete set of all 21 brands to be delivered from January to June 2023, and the Assortment Box with special sake containers featuring Japanese craftsmanship are very popular.
Also, KURA ONE's brand movie "KURA ONE TRIP." which introduces sake breweries and their regions is now online. On February 28 (Tue.), KURA ONE begins accepting applications worldwide for BtoB partners (restaurants, sake retailers, etc.) who can place orders for as little as 30 cans.
Video of press conference in Tokyo (English version): https://www.youtube.com/watch?v=aTTeue_Y2Ig
KURA ONE TRIP.: https://sake.japanpage.jp/en/pages/kuraone_movies
[Six new Collections. Now shipping to 100 countries around the world!]
-
“KURA ONE STORY. Subscription”: 3-4 cans of brands from domestic and international award-winning sake breweries delivered each month.
Price: 3,600 yen (tax not included) per month, limited to the first 2,000 slots - “KURA ONE Sales Commemorative Special Edition”: a special complete set of 21 cans of brands from award-winning sake breweries in Japan and overseas. Price: 23,000 yen (without tax) and limited to the first 500 sets.
- "KURA ONE Glass Sake Cup Box": includes 4 types of sake glasses of Kimoto Glassware used in famous restaurants, and 2 cans of KURA ONE. Price: 16,800 yen (without tax) and limited to the first 100 sets.
- "KURA ONE Traditional Craft Sake Cup Box": includes 3 types of traditional craft sake vessels such as Ceramic (Shigaraki) and Porcelain (Kutani) and 2 cans of KURA ONE. Price: 7,600 yen (without tax) and limited to the first 100 sets.
- "KURA ONE Temperature Sensitive Sake Cups Box": includes 2 mysterious sake vessels whose cherry blossom color changes depending on the sake temperature, and 2 cans of KURA ONE. Price: 5,400 yen (without tax) and limited to the first 100 sets.
- "KURA ONE Gacha Box": an experimental box for starters. You will enjoy 2 cans of KURA ONE after they arrive. Price: 1,700 yen (without tax)
- Shipping fees and taxes not included.
Click here to purchase (on the official website):
English: https://sake.japanpage.jp/en/pages/kuraone
French: https://sake.japanpage.jp/fr/pages/kuraone
Traditional Chinese: https://sake.japanpage.jp/zh-tw/pages/kuraone
Simplified Chinese: https://sake.japanpage.jp/zh-cn/pages/kuraone
Japanese: https://sake.japanpage.jp/pages/kuraone
[Now accepting applications for BtoB partners worldwide]
We are seeking BtoB sales partners to create new sake drinking scenes that integrate with the lifestyles of consumers in various parts of the world.
KURA ONE places importance on its target users and sales method. We will interview each company to make decisions based on the proposal content and their enthusiasm for the project, rather than on a first-come, first-served basis. This is not an exclusive offer for one company in one country. Currently, we have begun to conclude business negotiations with restaurants and sake retailers in Asia, Europe, and the United States.
Overview of BtoB sales partnerships / Transaction details / Privileges / How to apply (5 languages): https://sake.japanpage.jp/en/pages/kuraone_btob
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230223006067/en/
Contact information
KURA ONE
Public Relations: Tomoko Takiguchi
+81-80-8422-5844
info@greencreate.jp
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 21:00:00 EET | Press release
Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham, MSc, MD, FRCPC, dermatologist, SKiN Centre for Dermatology, Peterborough, Ontario, Canada, principal investigator for the Latitude PsO studies and presenting author. “These efficacy and safety results show it’s possible for a once-daily pill to deliver rapid, lasting skin clearance, highlighting the potential of zasoc
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 21:00:00 EET | Press release
Incyte (Nasdaq:INCY) today announced 54-week data evaluating the safety and efficacy of povorcitinib (INCB54707), an oral small-molecule highly-selective JAK1 inhibitor, from the pivotal Phase 3 STOP-HS clinical trial program in adult patients (≥18 years) with moderate to severe hidradenitis suppurativa (HS). The late-breaking oral presentation of these data is taking place at the 2026 American Academy of Dermatology (AAD) Annual Meeting, being held March 27-31, 2026, in Denver (Session: S034 – Late-Breaking Research: Session 2. Saturday, March 28, 2026, 1:00-4:00 p.m. MT). “The 54-week results from the STOP-HS program deliver compelling, long-term evidence supporting the potential of povorcitinib for patients with moderate to severe HS,” said Pablo J. Cagnoni, M.D., President and Global Head of Research and Development, Incyte. “Across both studies, povorcitinib demonstrated substantial and durable improvements over time in key measures of treatment success and meaningful clinical ben
AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 17:00:00 EET | Press release
Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-breaking session at the 2026 American Academy of Dermatology (AAD) Annual Meeting. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260328320362/en/ Atopic dermatitis is the most common inflammatory skin disorder in children, yet treatment options in the moderate-to-severe pediatric setting are limited.5 The disease can have a significant impact on quality of life for both the patients and their loved ones, with persistent itch and recurrent skin lesions often disrupting sleep, school and relationships.5-8 “Atopic dermatitis can affect many aspects of children’s lives including schoolwork, emotional development
Angelalign Technology (6699.HK) Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 21:56:00 EET | Press release
Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti
Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 19:46:00 EET | Press release
Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom